NutraSift: The nutraceutical innovation podcast

Mango Leaf- A mitochondrial bioenergetics enhancer from a tree that grows everywhere

5 min · 17 de jun de 2026
Portada del episodio Mango Leaf- A mitochondrial bioenergetics enhancer from a tree that grows everywhere

Descripción

Mangiferin (a xanthone in mango leaves) directly activates Complex II of the mitochondrial electron transport chain, a mechanism more commonly associated with pharmaceutical interventions than botanical ingredients. Nutriventia's Zynamite has clinical data showing improved reaction time and cognitive performance from this mechanism. The raw material is an agricultural waste product from the world's most widely grown tropical fruit. Publications of interest: https://pubmed.ncbi.nlm.nih.gov/29315239/, https://pmc.ncbi.nlm.nih.gov/articles/PMC7468873/, https://pubmed.ncbi.nlm.nih.gov/37447175/

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de NutraSift: The nutraceutical innovation podcast!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

78 episodios

episode Can social media serve as Real-Word Data for supplements? artwork

Can social media serve as Real-Word Data for supplements?

What if the millions of supplement experiences shared online could point us toward what actually works? We dig into a first-of-its-kind study that matched 216,350 Reddit comments against 15,760 clinical-trial records to test whether social media chatter lines up with real evidence. The findings are striking: the most-discussed ingredients were more than 3× as likely to have trial evidence behind them (39% vs. 11%), and the effect scaled steadily. The more a benefit was discussed, the stronger its link to clinical support (odds ratios climbing from 2.1 to 5.5). We unpack why this matters. Supplements largely escape the post-market surveillance that tracks prescription drugs, leaving over-the-counter use nearly invisible, even as lived experiences pile up in public forums. We explore how consensus (not just volume) carries independent signal, how contested claims might hint at personalised supplementation, and why aggregated social data, treated carefully as a measurement instrument, could become a credible real-world resource for prioritising hypotheses and designing sharper studies. Not a replacement for clinical trials, but a powerful new lens. You can find the full publication: https://www.medrxiv.org/content/10.64898/2026.06.26.26356690v1 [https://www.medrxiv.org/content/10.64898/2026.06.26.26356690v1]

10 de jul de 20269 min